No abstract available
MeSH terms
-
Amlodipine / adverse effects
-
Amlodipine / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / adverse effects
-
Atorvastatin / administration & dosage
-
Atorvastatin / adverse effects
-
Atorvastatin / therapeutic use
-
Calcium Channel Blockers / adverse effects
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / epidemiology
-
Clopidogrel / adverse effects
-
Clopidogrel / therapeutic use
-
Gout / drug therapy*
-
Gout / epidemiology
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Losartan / adverse effects
-
Losartan / therapeutic use
-
Purinergic P2Y Receptor Antagonists / adverse effects
-
Risk Factors
-
Uric Acid / antagonists & inhibitors*
-
Uric Acid / blood
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Calcium Channel Blockers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Purinergic P2Y Receptor Antagonists
-
Amlodipine
-
Uric Acid
-
Atorvastatin
-
Clopidogrel
-
Losartan